Researchers at the University of Colorado Anschutz Medical Campus have found that many pregnant Black Americans have low levels of choline, an essential nutrient that aids in prenatal brain development. Stress caused by institutional racism may play a role.
What you need to know: Summit Biolabs, an early-stage molecular diagnostics company, is partnering with the Colorado Center for Personalized Medicine at CU School of Medicine involving research, collaboration and development of saliva liquid-biopsy tests for early cancer detection and diagnosis of viral contagions such as COVID-19.
What you need to know: CU Anschutz researchers discovered that the subtype identities of some new neurons, previously thought to be random, actually depends on odor stimulation. The study hints that life-long olfactory sensory neurogenesis may have an important adaptive function in addition to simple repair.
Olfactory sensory neurons (OSNs) are nasal neurons that make use of hundreds of different types of odorant receptors to analyze odorous chemicals in our external world and send that information to our brain. These neurons have the unusual ability to undergo turnover throughout life – a process understood to happen due to the special vulnerability of these neurons to environmental insults, such as viruses.
What you need to know: CCPM's significant advancements in making pharmacogenomics a standard of care are already providing benefits. With plans to expand the provision of personalized healthcare, patients will soon have access to more clinically actionable results.
BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced that it has formed a new data partnership with the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus that will incorporate clinical and genomic-consented records and biobank samples representing an ethnically diverse patient population from across the entire UCHealth system.
Kelsea Pieters
